Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence

IF 2.6 3区 医学 Q3 ONCOLOGY Seminars in Radiation Oncology Pub Date : 2023-01-01 DOI:10.1016/j.semradonc.2022.10.009
Nicholas S. Moore MD , Alan McWilliam PhD , Sanjay Aneja MD
{"title":"Bladder Cancer Radiation Oncology of the Future: Prognostic Modelling, Radiomics, and Treatment Planning With Artificial Intelligence","authors":"Nicholas S. Moore MD ,&nbsp;Alan McWilliam PhD ,&nbsp;Sanjay Aneja MD","doi":"10.1016/j.semradonc.2022.10.009","DOIUrl":null,"url":null,"abstract":"<div><p>Machine learning (ML) and artificial intelligence (AI) have demonstrated potential to improve the care of radiation oncology<span><span> patients. Here we review recent advances applicable to the care of bladder cancer, with an eye towards studies that may suggest next steps in clinical implementation. Algorithms have been applied to clinical records, pathology, and </span>radiology<span> data to generate accurate predictive models for prognosis and clinical outcomes. AI has also shown increasing utility for auto-contouring and efficient creation of workflows involving multiple treatment plans. As technologies progress towards routine clinical use for bladder cancer patients, we also discuss emerging methods to improve interpretability and reliability of algorithms.</span></span></p></div>","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"33 1","pages":"Pages 70-75"},"PeriodicalIF":2.6000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1053429622000637","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 3

Abstract

Machine learning (ML) and artificial intelligence (AI) have demonstrated potential to improve the care of radiation oncology patients. Here we review recent advances applicable to the care of bladder cancer, with an eye towards studies that may suggest next steps in clinical implementation. Algorithms have been applied to clinical records, pathology, and radiology data to generate accurate predictive models for prognosis and clinical outcomes. AI has also shown increasing utility for auto-contouring and efficient creation of workflows involving multiple treatment plans. As technologies progress towards routine clinical use for bladder cancer patients, we also discuss emerging methods to improve interpretability and reliability of algorithms.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
未来的膀胱癌放射肿瘤学:预后建模、放射组学和人工智能治疗计划
机器学习(ML)和人工智能(AI)已显示出改善放射肿瘤学患者护理的潜力。在此,我们回顾了适用于膀胱癌症治疗的最新进展,着眼于可能建议临床实施下一步的研究。算法已应用于临床记录、病理学和放射学数据,以生成准确的预后和临床结果预测模型。人工智能在自动轮廓绘制和高效创建涉及多个治疗计划的工作流程方面也显示出越来越大的实用性。随着技术向癌症患者的常规临床应用发展,我们还讨论了提高算法可解释性和可靠性的新方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.80
自引率
0.00%
发文量
48
审稿时长
>12 weeks
期刊介绍: Each issue of Seminars in Radiation Oncology is compiled by a guest editor to address a specific topic in the specialty, presenting definitive information on areas of rapid change and development. A significant number of articles report new scientific information. Topics covered include tumor biology, diagnosis, medical and surgical management of the patient, and new technologies.
期刊最新文献
Radiation as an Immune Modulator: Where We Are With Modern Total Body Irradiation. Radiation for Multiple Myeloma in the Era of Novel Agents: Indications, Safety, and Dose Selection. Rising to the Top: How Immune-Checkpoint Inhibitors are Changing the Landscape of Treatment for Classic Hodgkin Lymphoma. Translating Between Radiation Dose and Late Toxicity for Lymphoma Survivors: Implications on Toxicity Counseling and Survivorship. Advanced Stage Hodgkin and Diffuse Large B-Cell Lymphomas: Is There Still a Role for Consolidation Radiotherapy in the PET Era?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1